Cargando…
Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice
Tumor progression depends on tumor milieu, which influences neovasculature formation and immunosuppression. Combining immunotherapy with antiangiogenic/antivascular therapy might be an effective therapeutic approach. The aim of our study was to elaborate an anticancer therapeutic strategy based on t...
Autores principales: | Jarosz-Biej, Magdalena, Smolarczyk, Ryszard, Cichoń, Tomasz, Kułach, Natalia, Czapla, Justyna, Matuszczak, Sybilla, Szala, Stanisław |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Basel
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633448/ https://www.ncbi.nlm.nih.gov/pubmed/25801067 http://dx.doi.org/10.1007/s00005-015-0337-y |
Ejemplares similares
-
Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
por: Kułach, Natalia, et al.
Publicado: (2021) -
M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2018) -
Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
por: Czapla, Justyna, et al.
Publicado: (2023) -
D-K(6)L(9) Peptide Combination with IL-12 Inhibits the Recurrence of Tumors in Mice
por: Cichoń, Tomasz, et al.
Publicado: (2014) -
Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2019)